| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ELMOD2 ARHGAP11A CHN1 TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.24e-09 | 279 | 99 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 ERCC6 TBC1D3H TBC1D3L TBC1D3D ELMOD2 ADRM1 ARHGAP11A CHN1 TBC1D3C PRKCD TBC1D3I TBC1D3G AIM2 TBC1D3K TBC1D3F | 2.21e-08 | 656 | 99 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ELMOD2 DOCK10 ARHGAP11A CHN1 TBC1D3C ELMO1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.91e-08 | 507 | 99 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ELMOD2 DOCK10 ARHGAP11A CHN1 TBC1D3C ELMO1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.91e-08 | 507 | 99 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E TBC1D3 ERCC6 TBC1D3H TBC1D3L TBC1D3D ELMOD2 ING2 ADRM1 DOCK10 ARHGAP11A CHN1 TBC1D3C ELMO1 PRKCD TBC1D3I TBC1D3G AIM2 TBC1D3K TBC1D3F | 1.77e-05 | 1418 | 99 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 ERCC6 TBC1D3H TBC1D3L TBC1D3D ELMOD2 ADRM1 ARHGAP11A CHN1 TBC1D3C PRKCD IL1B TBC1D3I TBC1D3G AIM2 TBC1D3K TBC1D3F | 3.19e-05 | 1233 | 99 | 18 | GO:0140677 |
| GeneOntologyMolecularFunction | methylated histone binding | 8.84e-04 | 86 | 99 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 9.64e-04 | 88 | 99 | 4 | GO:0140034 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C TBC1D3I SNX9 TBC1D3G TBC1D3K TBC1D3F | 7.32e-12 | 244 | 96 | 14 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C PPARGC1B PRKCD TBC1D3I SNX9 TBC1D3G AIM2 TBC1D3K EPHA4 TBC1D3F | 1.43e-11 | 499 | 96 | 18 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C TBC1D3I SNX9 TBC1D3G TBC1D3K EPHA4 TBC1D3F | 4.21e-11 | 335 | 96 | 15 | GO:0043087 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.61e-11 | 109 | 96 | 10 | GO:0090630 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C PPARGC1B PRKCD TBC1D3I SNX9 TBC1D3G AIM2 TBC1D3K EPHA4 TBC1D3F | 1.06e-07 | 878 | 96 | 18 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C PPARGC1B PRKCD IL1B TBC1D3I SNX9 TBC1D3G AIM2 TBC1D3K EPHA4 TBC1D3F | 2.22e-07 | 1028 | 96 | 19 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK10 ARHGAP11A CHN1 TBC1D3C PPARGC1B PLCL2 PRKCD IRAK3 PLCL1 IL1B TBC1D3I SNX9 TBC1D3G AIM2 TBC1D3K EPHA4 TBC1D3F | 4.98e-07 | 1430 | 96 | 22 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 9.31e-05 | 51 | 96 | 4 | GO:1902459 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 2.38e-06 | 45 | 100 | 5 | GO:0099524 | |
| GeneOntologyCellularComponent | cytosolic region | 2.14e-05 | 70 | 100 | 5 | GO:0099522 | |
| GeneOntologyCellularComponent | Sin3-type complex | 1.53e-04 | 22 | 100 | 3 | GO:0070822 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.26e-12 | 49 | 97 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.91e-12 | 53 | 97 | 9 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 9.82e-12 | 55 | 97 | 9 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 9.82e-12 | 55 | 97 | 9 | IPR000195 |
| Domain | Zinc_finger_PHD-type_CS | 1.08e-06 | 65 | 97 | 6 | IPR019786 | |
| Domain | PHD | 2.53e-06 | 75 | 97 | 6 | PF00628 | |
| Domain | PH_12 | 2.69e-06 | 6 | 97 | 3 | PF16457 | |
| Domain | Znf_PHD-finger | 3.44e-06 | 79 | 97 | 6 | IPR019787 | |
| Domain | PHD | 6.89e-06 | 89 | 97 | 6 | SM00249 | |
| Domain | Znf_PHD | 7.84e-06 | 91 | 97 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.01e-05 | 95 | 97 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.07e-05 | 96 | 97 | 6 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.18e-04 | 147 | 97 | 6 | IPR011011 | |
| Domain | Actinin_actin-bd_CS | 2.23e-04 | 23 | 97 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.23e-04 | 23 | 97 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.23e-04 | 23 | 97 | 3 | PS00019 | |
| Domain | ING | 2.64e-04 | 5 | 97 | 2 | SM01408 | |
| Domain | ING_N_histone_binding | 2.64e-04 | 5 | 97 | 2 | IPR024610 | |
| Domain | ING | 2.64e-04 | 5 | 97 | 2 | PF12998 | |
| Domain | ING_fam | 2.64e-04 | 5 | 97 | 2 | IPR028651 | |
| Domain | LON | 3.95e-04 | 6 | 97 | 2 | SM00464 | |
| Domain | ZF_BED | 3.95e-04 | 6 | 97 | 2 | PS50808 | |
| Domain | zf-BED | 3.95e-04 | 6 | 97 | 2 | PF02892 | |
| Domain | ELMO | 3.95e-04 | 6 | 97 | 2 | PS51335 | |
| Domain | LON_N | 3.95e-04 | 6 | 97 | 2 | PS51787 | |
| Domain | ELMO_CED12 | 3.95e-04 | 6 | 97 | 2 | PF04727 | |
| Domain | LON_substr-bd_dom | 3.95e-04 | 6 | 97 | 2 | IPR003111 | |
| Domain | LON_substr_bdg | 3.95e-04 | 6 | 97 | 2 | PF02190 | |
| Domain | ELMO_dom | 3.95e-04 | 6 | 97 | 2 | IPR006816 | |
| Domain | - | 5.46e-04 | 449 | 97 | 9 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 6.39e-04 | 459 | 97 | 9 | IPR013083 | |
| Domain | HATC_C_dom | 7.32e-04 | 8 | 97 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 7.32e-04 | 8 | 97 | 2 | PF05699 | |
| Domain | C2 | 8.71e-04 | 142 | 97 | 5 | PS50004 | |
| Domain | - | 1.05e-03 | 148 | 97 | 5 | 2.60.40.150 | |
| Domain | IG_FLMN | 1.17e-03 | 10 | 97 | 2 | SM00557 | |
| Domain | Filamin | 1.42e-03 | 11 | 97 | 2 | PF00630 | |
| Domain | ZnF_BED | 1.42e-03 | 11 | 97 | 2 | SM00614 | |
| Domain | FILAMIN_REPEAT | 1.42e-03 | 11 | 97 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.42e-03 | 11 | 97 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.42e-03 | 11 | 97 | 2 | IPR017868 | |
| Domain | C2_dom | 1.65e-03 | 164 | 97 | 5 | IPR000008 | |
| Domain | Znf_BED | 1.70e-03 | 12 | 97 | 2 | IPR003656 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.68e-03 | 15 | 97 | 2 | IPR001711 | |
| Domain | EF-hand_like | 2.68e-03 | 15 | 97 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 2.68e-03 | 15 | 97 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.68e-03 | 15 | 97 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.68e-03 | 15 | 97 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 2.68e-03 | 15 | 97 | 2 | PF00387 | |
| Domain | PLCYc | 2.68e-03 | 15 | 97 | 2 | SM00149 | |
| Domain | C1_1 | 3.24e-03 | 57 | 97 | 3 | PF00130 | |
| Domain | PH_DOMAIN | 3.35e-03 | 279 | 97 | 6 | PS50003 | |
| Domain | PI-PLC-X | 3.87e-03 | 18 | 97 | 2 | PF00388 | |
| Domain | PLCXc | 3.87e-03 | 18 | 97 | 2 | SM00148 | |
| Domain | PUA-like_domain | 4.31e-03 | 19 | 97 | 2 | IPR015947 | |
| Domain | PIPLC_X_DOMAIN | 4.31e-03 | 19 | 97 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.31e-03 | 19 | 97 | 2 | IPR000909 | |
| Domain | ZF_DAG_PE_1 | 4.50e-03 | 64 | 97 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.50e-03 | 64 | 97 | 3 | PS50081 | |
| Domain | C1 | 4.70e-03 | 65 | 97 | 3 | SM00109 | |
| Domain | CH | 4.70e-03 | 65 | 97 | 3 | SM00033 | |
| Domain | PE/DAG-bd | 4.90e-03 | 66 | 97 | 3 | IPR002219 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C FBXO47 TBC1D3I TBC1D3G TBC1D3K | 1.00e-09 | 99 | 68 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.28e-25 | 11 | 102 | 10 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 8.64e-08 | 74 | 102 | 6 | 16625196 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 9.78e-08 | 4 | 102 | 3 | 12359748 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 8406013 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 12604796 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 8471161 | ||
| Pubmed | UNC13B FLNB KDM5B OGT ERG OXR1 UBE4B LONRF1 ZMYND8 PIAS1 UBE2O PTPRK ADAMTS9 UBE3A MACF1 SMARCE1 | 1.05e-06 | 1285 | 102 | 16 | 35914814 | |
| Pubmed | 3.31e-06 | 407 | 102 | 9 | 12693553 | ||
| Pubmed | 3.97e-06 | 11 | 102 | 3 | 19015242 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34859819 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30755509 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31589911 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 36650454 | ||
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 8.52e-06 | 2 | 102 | 2 | 9694715 | |
| Pubmed | Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. | 8.52e-06 | 2 | 102 | 2 | 16465410 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19996098 | ||
| Pubmed | Identification and characterization of a new phospholipase C-like protein, PLC-L(2). | 8.52e-06 | 2 | 102 | 2 | 10581172 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34143493 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17301177 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11481424 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 8.52e-06 | 2 | 102 | 2 | 12525170 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19553601 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20097266 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17254016 | ||
| Pubmed | Expression of novel ING variants is regulated by thyroid hormone in the Xenopus laevis tadpole. | 8.52e-06 | 2 | 102 | 2 | 11600495 | |
| Pubmed | AIM2 Inflammasome Is Critical for dsDNA-Induced IL-1β Secretion in Human Dental Pulp Cells. | 8.52e-06 | 2 | 102 | 2 | 29178062 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25781467 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34638625 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIER2 VRK1 OGT ERCC6 ARHGAP11A ADNP PIAS1 UBE2O PHF3 SMARCE1 | 1.25e-05 | 608 | 102 | 10 | 36089195 |
| Pubmed | 1.48e-05 | 268 | 102 | 7 | 33640491 | ||
| Pubmed | 2.29e-05 | 19 | 102 | 3 | 22984288 | ||
| Pubmed | Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal. | 2.29e-05 | 19 | 102 | 3 | 28554894 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 36037355 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23639135 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19052845 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 38251918 | ||
| Pubmed | Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome. | 2.55e-05 | 3 | 102 | 2 | 34006824 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 2.55e-05 | 3 | 102 | 2 | 21030649 | |
| Pubmed | IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes. | 2.55e-05 | 3 | 102 | 2 | 21804018 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 25760020 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23399561 | ||
| Pubmed | A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling. | 2.55e-05 | 3 | 102 | 2 | 27305909 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12393796 | ||
| Pubmed | Protein kinase Cδ regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis. | 2.55e-05 | 3 | 102 | 2 | 21346188 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11153914 | ||
| Pubmed | Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation. | 2.55e-05 | 3 | 102 | 2 | 21757756 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11252955 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24623763 | ||
| Pubmed | EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin. | 2.55e-05 | 3 | 102 | 2 | 17785182 | |
| Pubmed | IL-1β turnover by the UBE2L3 ubiquitin conjugating enzyme and HECT E3 ligases limits inflammation. | 2.55e-05 | 3 | 102 | 2 | 37474493 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17929852 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 34220810 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24945349 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 38880187 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23935506 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33678651 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 37326017 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26706316 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33760111 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.86e-05 | 220 | 102 | 6 | 35785414 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 5.09e-05 | 4 | 102 | 2 | 22802962 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17719550 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 25880753 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 28341745 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 24701032 | ||
| Pubmed | HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation. | 5.09e-05 | 4 | 102 | 2 | 20621832 | |
| Pubmed | 6.27e-05 | 591 | 102 | 9 | 15231748 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.82e-05 | 341 | 102 | 7 | 32971831 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B FLNC VRK1 OGT ZMYND8 ADNP RAB10 ZBED4 UPF2 MACF1 SMARCE1 CLP1 | 7.98e-05 | 1082 | 102 | 12 | 38697112 |
| Pubmed | PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. | 8.47e-05 | 5 | 102 | 2 | 16600910 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 12006559 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 26655906 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 17360453 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 24996056 | ||
| Pubmed | alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits. | 8.47e-05 | 5 | 102 | 2 | 17785183 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 19366992 | ||
| Pubmed | Mutant α2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome. | 8.47e-05 | 5 | 102 | 2 | 28346224 | |
| Pubmed | 1.15e-04 | 371 | 102 | 7 | 15747579 | ||
| Pubmed | OGT ERCC6 PARP2 ZMYND8 PIAS1 RAB10 ZBED6 PHF3 ELAPOR1 ANKRD11 MACF1 SMARCE1 CLP1 CEP170B | 1.21e-04 | 1497 | 102 | 14 | 31527615 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 24703950 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 36961815 | ||
| Pubmed | Role of inflammasomes in host defense against Citrobacter rodentium infection. | 1.27e-04 | 6 | 102 | 2 | 22461621 | |
| Pubmed | The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. | 1.27e-04 | 6 | 102 | 2 | 22406621 | |
| Pubmed | SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. | 1.27e-04 | 6 | 102 | 2 | 22661230 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 30982580 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 20412381 | ||
| Pubmed | The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. | 1.27e-04 | 6 | 102 | 2 | 20016594 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 25673830 | ||
| Pubmed | VRK1 OGT UBE4B ADRM1 PIAS1 USP19 RAB10 ZBED4 UPF2 UBE3A PLEKHA3 ANKRD11 PGP | 1.37e-04 | 1327 | 102 | 13 | 32694731 | |
| Pubmed | 1.77e-04 | 37 | 102 | 3 | 34147029 | ||
| Pubmed | The developing mouse coronal suture at single-cell resolution. | 1.77e-04 | 37 | 102 | 3 | 34376651 | |
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 22969086 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 30794604 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 16754670 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 22286270 | ||
| Pubmed | ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. | 1.77e-04 | 7 | 102 | 2 | 16728974 | |
| Pubmed | Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. | 1.77e-04 | 7 | 102 | 2 | 19217413 | |
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 16076904 | ||
| Pubmed | Inflammasome activation and IL-1 signaling during placental malaria induce poor pregnancy outcomes. | 1.77e-04 | 7 | 102 | 2 | 32181339 | |
| Interaction | HDAC1 interactions | MIER2 FLNB KDM5B OGT ERCC6 ING1 ING2 ADRM1 PARP2 ZMYND8 ADNP USP19 SMARCE1 SUMO2 DCTN4 CLP1 SNX9 AIM2 | 6.68e-06 | 1108 | 99 | 18 | int:HDAC1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C FBXO47 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.00e-14 | 149 | 102 | 11 | chr17q12 |
| Cytoband | 17q12 | 2.97e-06 | 99 | 102 | 5 | 17q12 | |
| GeneFamily | PHD finger proteins | 5.18e-07 | 90 | 60 | 6 | 88 | |
| GeneFamily | Zinc fingers BED-type|Pseudoautosomal region 1 | 1.61e-04 | 6 | 60 | 2 | 64 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.79e-03 | 19 | 60 | 2 | 832 | |
| GeneFamily | Zinc fingers MYND-type | 2.18e-03 | 21 | 60 | 2 | 87 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 3.80e-06 | 168 | 100 | 7 | M6874 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.74e-05 | 294 | 100 | 8 | M41112 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB KDM5B VRK1 OGT ZMYND8 ARHGAP11A ADNP UPF2 PTPRK UBE3A PHF3 MACF1 EPHA4 | 2.27e-05 | 856 | 100 | 13 | M4500 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 1.03e-08 | 90 | 100 | 8 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 7.50e-07 | 213 | 100 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 7.50e-07 | 213 | 100 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 2.16e-06 | 242 | 100 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D CRABP2 TBC1D3C ADAMTS9 TBC1D3G TBC1D3K TBC1D3F | 2.74e-06 | 320 | 100 | 10 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | FLNC TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 7.28e-06 | 281 | 100 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | FLNC TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3G TBC1D3K TBC1D3F | 7.28e-06 | 281 | 100 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | FLNB FLNC TBC1D3 TRPA1 TBC1D3H TBC1D3L TBC1D3D ELMOD2 LONRF1 CRABP2 TBC1D3C ADAMTS9 TBC1D3G TCEAL9 TBC1D3K EPHA4 TBC1D3F | 2.55e-05 | 1153 | 100 | 17 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.27e-04 | 21 | 100 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.14e-07 | 193 | 102 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.14e-07 | 193 | 102 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 156 | 102 | 6 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 156 | 102 | 6 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 184 | 102 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.89e-06 | 189 | 102 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.89e-06 | 189 | 102 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.68e-06 | 194 | 102 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 155 | 102 | 5 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-05 | 156 | 102 | 5 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-05 | 158 | 102 | 5 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-05 | 158 | 102 | 5 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 162 | 102 | 5 | 860ebf2390b4ad86475ad54717cbefcf61cd3b2a | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 162 | 102 | 5 | 14e9f8aaba308619eb9da90796c336e76cedac1f | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-05 | 163 | 102 | 5 | ae9c5eb19657ea94b7f2357cbc8679acd697b8fe | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 164 | 102 | 5 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 169 | 102 | 5 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-05 | 169 | 102 | 5 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.16e-05 | 175 | 102 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.30e-05 | 176 | 102 | 5 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 177 | 102 | 5 | 7bc92314b22a876296a4e2db51e7fb0fdfd69379 | |
| ToppCell | facs-Lung-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-05 | 177 | 102 | 5 | a8a7b135d86701ab9acac8273061debf8cce79a0 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.75e-05 | 179 | 102 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.75e-05 | 179 | 102 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 180 | 102 | 5 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-05 | 183 | 102 | 5 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.38e-05 | 183 | 102 | 5 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.38e-05 | 183 | 102 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-05 | 183 | 102 | 5 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 184 | 102 | 5 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 185 | 102 | 5 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 6.72e-05 | 185 | 102 | 5 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.72e-05 | 185 | 102 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 185 | 102 | 5 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.07e-05 | 187 | 102 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.43e-05 | 189 | 102 | 5 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 189 | 102 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 7.43e-05 | 189 | 102 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 189 | 102 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.62e-05 | 190 | 102 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.81e-05 | 191 | 102 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 191 | 102 | 5 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 8.00e-05 | 192 | 102 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.00e-05 | 192 | 102 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.00e-05 | 192 | 102 | 5 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.40e-05 | 194 | 102 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 8.40e-05 | 194 | 102 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 194 | 102 | 5 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 8.61e-05 | 195 | 102 | 5 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 195 | 102 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.82e-05 | 196 | 102 | 5 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.03e-05 | 197 | 102 | 5 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.03e-05 | 197 | 102 | 5 | 9791923feefbd78810242113ad2a08ce4c2bb4f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.03e-05 | 197 | 102 | 5 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 198 | 102 | 5 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-05 | 198 | 102 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 198 | 102 | 5 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 9.25e-05 | 198 | 102 | 5 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 198 | 102 | 5 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.47e-05 | 199 | 102 | 5 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.47e-05 | 199 | 102 | 5 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.69e-05 | 200 | 102 | 5 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tem|URO / Disease, condition lineage and cell class | 9.69e-05 | 200 | 102 | 5 | 8b7bfe6411de9528603481f6e5612cbbb8471cf6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 200 | 102 | 5 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.82e-05 | 3 | 91 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.82e-05 | 3 | 91 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | asthma, Eczema, allergic rhinitis | 5.46e-04 | 121 | 91 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Seizures | 5.84e-04 | 218 | 91 | 5 | C0036572 | |
| Disease | uveitis (is_implicated_in) | 7.18e-04 | 13 | 91 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | Congenital pontocerebellar hypoplasia | 7.18e-04 | 13 | 91 | 2 | C0266468 | |
| Disease | Metabolic Bone Disorder | 8.36e-04 | 14 | 91 | 2 | C0005944 | |
| Disease | Osteopenia | 9.62e-04 | 15 | 91 | 2 | C0029453 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.10e-03 | 16 | 91 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Pontoneocerebellar hypoplasia | 1.10e-03 | 16 | 91 | 2 | cv:C1261175 | |
| Disease | Craniofacial Abnormalities | 1.41e-03 | 156 | 91 | 4 | C0376634 | |
| Disease | osteoporosis (implicated_via_orthology) | 1.55e-03 | 19 | 91 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | response to methotrexate, neurotoxicity | 1.55e-03 | 19 | 91 | 2 | EFO_0011057, GO_0031427 | |
| Disease | CCL4 measurement | 1.72e-03 | 20 | 91 | 2 | EFO_0004751 | |
| Disease | Malignant neoplasm of breast | FLNB ERCC6 ARHGAP11A PPARGC1B GUCY1A2 FKTN ELAPOR1 ANKRD30A MACF1 IL1B | 1.75e-03 | 1074 | 91 | 10 | C0006142 |
| Disease | alcohol drinking | 2.03e-03 | 81 | 91 | 3 | EFO_0004329 | |
| Disease | Epilepsy, Cryptogenic | 2.11e-03 | 82 | 91 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.11e-03 | 82 | 91 | 3 | C0751111 | |
| Disease | Aura | 2.11e-03 | 82 | 91 | 3 | C0236018 | |
| Disease | platelet component distribution width | 2.33e-03 | 755 | 91 | 8 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAAKKKATMQGDREQ | 1011 | Q9H2P0 | |
| GLCAMAEKKSSPEKN | 331 | Q9H172 | |
| KNINPEKDASFKICM | 81 | Q8IZ81 | |
| DCPHMKEKGALKQNK | 621 | Q92556 | |
| EKGDPVKMSNGNDKV | 1541 | Q6UB99 | |
| VKMSNGNDKVAPSKD | 1546 | Q6UB99 | |
| MGTEKESPEPDCQKQ | 1 | Q8NC06 | |
| VRNEDTMKCKEGDKV | 296 | O14862 | |
| QNIDGKELCKMTKDD | 161 | P11308 | |
| DVCVPKATHQKEMDK | 936 | Q9BXX3 | |
| CESSQPQVEEKMKKC | 291 | A6NC57 | |
| IEFDDCSPGKMKIKD | 271 | Q9Y4F5 | |
| EKCQDGIMKKEGKDN | 1351 | Q03468 | |
| GNKCDMDDKRVVPKG | 121 | P61026 | |
| ENKMVCEQKLLKGEG | 91 | P29373 | |
| QKVKCKMEDDAVPAA | 266 | Q8N0W5 | |
| KPSGEMDEVGVQKCK | 21 | Q2M385 | |
| KANKDRTEDKQDGMP | 56 | Q9UGN5 | |
| ADGPKQMKCSFQDLD | 26 | P01584 | |
| LKEMVKSKAECDNVG | 246 | Q9P2G4 | |
| DEANQPFCAVKMKEA | 21 | Q05655 | |
| KLKKQGETPNEVCMF | 446 | Q17RB8 | |
| NAGEFLDMKDQSCKP | 96 | Q6UXG2 | |
| GSCVNNSEEKDVPKM | 231 | P54764 | |
| KVKMDCQETPEGYKV | 2426 | O75369 | |
| NNQESDCVSKKKMVP | 291 | A6NDG6 | |
| AIEGPSEAKMSCKDN | 1386 | Q14315 | |
| MIPIKDIKEKSNVGC | 151 | O14626 | |
| PAEKNVDLCKEMVDG | 246 | Q8N5Y2 | |
| GCPTPKCENEKEMKS | 261 | Q9UGL1 | |
| PECNSVKKEAQKVMC | 296 | Q1L5Z9 | |
| KKPESKRNEEACNMP | 521 | Q9Y616 | |
| PVMSDRECQKTEQGK | 156 | A4D1T9 | |
| PKCRGDNEKTMDKST | 256 | Q9H160 | |
| NSSKICQDMKEPEDN | 186 | Q9BXL5 | |
| CVQKADDGCSPNKMK | 36 | O95274 | |
| DDGCSPNKMKTVKCA | 41 | O95274 | |
| MGVNQAPEKLDKQCE | 3796 | Q9UPN3 | |
| QEPSGMNAEGKSKDK | 546 | Q7Z442 | |
| CSKKKDAAVMNQEPA | 266 | Q99706 | |
| KENMPCGETAEFKQK | 466 | Q8N573 | |
| NMPHDDNNKCKEEGV | 441 | Q9P2N4 | |
| GDKQMKNSNFPAEVK | 1641 | Q96BY6 | |
| MSDNKERKSQGFPKE | 1 | Q5T0U0 | |
| TCKDEKGKQEMETGQ | 31 | Q7Z4B0 | |
| ENMGFQCLKIESKDP | 131 | O75072 | |
| GAPKNKDVQCDKIIM | 296 | Q5VTH9 | |
| KIQMAVCSKPGSAQK | 196 | Q5MNV8 | |
| KEPGKMDQEAQEQGK | 4191 | Q8NDH2 | |
| QCSKMVPNDCKPDLK | 246 | P15882 | |
| ENMPSAEAKLKKNRC | 56 | Q9UJW0 | |
| KNEPEDTEDKEGCQM | 611 | Q9ULU4 | |
| EGCQMDKEPSAVKKK | 621 | Q9ULU4 | |
| DSLPANKCKKEIMVG | 186 | Q8N344 | |
| NKCKKEIMVGPQFQA | 191 | Q8N344 | |
| NESKADCLDMDPKAP | 436 | Q15262 | |
| VKIVKMKCPDGGDNA | 751 | O15294 | |
| MEEKDSLPNNKEKDC | 11 | Q9HAU5 | |
| ICKKCPENMKGVTED | 96 | Q5HYA8 | |
| PATLFKDKMKCTVNN | 61 | Q9UPX6 | |
| KPEASGSENKDKVME | 391 | P33402 | |
| IKSGPKEQKSMSCEE | 896 | Q6P4F7 | |
| NDMKEKPICVEQGQK | 136 | P17081 | |
| EQKCEAVGKFTKAMD | 396 | Q9Y5X1 | |
| ANKGEEKKDDENIPM | 326 | Q969G3 | |
| SENIKKNCQIGMKTP | 311 | Q96DL1 | |
| CPKCRGENEKTMDKA | 396 | Q9UK53 | |
| LMEDDGKQNKRVCGK | 361 | Q7RTY7 | |
| IFDPEHKKVCQDMKQ | 416 | Q9UPR0 | |
| PCVKADSTQDKKAPM | 191 | Q86YN6 | |
| KAGCSPAVQMKIKEL | 46 | O75925 | |
| SQPKTMGHQDKKDLC | 246 | B9A6J9 | |
| AQEKQSPMKKFRECS | 221 | A4IF30 | |
| PEARKESDQACGKMD | 181 | Q9H930 | |
| MKCNRPSVKVEDKDF | 251 | O00327 | |
| MQNNAKPEQKEGDTK | 381 | Q16186 | |
| MGEEANDDKKPTTKF | 1 | Q92989 | |
| SQPKTMGHQDKKDLC | 246 | P0C7X1 | |
| CDIFDPEQKKVAQDM | 386 | Q15111 | |
| RNPGKDDCAKEEMAV | 251 | O94966 | |
| KMCLDNGAQIDPVEK | 256 | O75762 | |
| SKQMPCKKNEENEDS | 826 | Q6AWC2 | |
| KGAPNNSCSEIKMNK | 101 | Q05086 | |
| SQPKTMGHQDKKDLC | 246 | A6NER0 | |
| DPEALQKMAKCAVQD | 56 | Q8NCR6 | |
| RVGIEEKKAPKMCSQ | 436 | O95155 | |
| EKKAPKMCSQPAVSQ | 441 | O95155 | |
| DIGKKQSEPNSMDKN | 241 | Q6U841 | |
| PEKNCAQGEGSMAKK | 371 | Q9C0C9 | |
| NKDVCDPGNTKVMDK | 331 | P02774 | |
| GEKKNEALMECKAKP | 266 | Q92576 | |
| SCMNEKAIEKADAKP | 141 | P78562 | |
| MADEKPKEGVKTENN | 1 | P61956 | |
| GQAEKEAACEPKEMK | 321 | O14795 | |
| MKSCQKMEGKPENES | 1 | Q9UHQ7 | |
| SQPKTMGHQDKKDLC | 246 | A0A087X179 | |
| NIASLMDKCFPEKNK | 281 | Q99986 | |
| EECVKIANAKFKPEM | 171 | Q9HB20 | |
| GKDPMIQEEENNFKC | 191 | O43296 | |
| KMVAEGVNKEAKQPA | 46 | P86452 | |
| PCKDSALQMGSIKEK | 136 | Q9UL58 | |
| SQPKTMGHQDKKDLC | 246 | A0A087WVF3 | |
| SQPKTMGHQDKKDLC | 246 | Q6DHY5 | |
| SQPKTMGHQDKKDLC | 246 | Q8IZP1 | |
| SQPKTMGHQDKKDLC | 246 | A0A087X1G2 | |
| SQPKTMGHQDKKDLC | 246 | A0A087WXS9 | |
| SQPKTMGHQDKKDLC | 246 | Q6IPX1 | |
| MENNLKTCPKEDGDF | 1 | O75132 | |
| PQSNKFVKCADMKDR | 496 | Q2WGJ6 |